Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,160,782 papers from all fields of science
Search
Sign In
Create Free Account
20 ML Bupivacaine liposome 13.3 MG/ML Injection [Exparel]
Known as:
20 ML Exparel 13.3 MG/ML Injection
, BUPIVACAINE 13.3 mg in 1 mL INFILTRATION INJECTION, SUSPENSION, LIPOSOMAL [EXPAREL]
, EXPAREL 1.3 % in 20 ML Injection
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Bupivacaine
Exparel
Injection
Broader (1)
Bupivacaine liposome Injection [Exparel]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Lumbar 3-Lumbar 5 Robotic-Assisted Endoscopic Transforaminal Lumbar Interbody Fusion: 2-Dimensional Operative Video.
Jason I. Liounakos
,
Michael Y. Wang
Operative Neurosurgery
2019
Corpus ID: 208813077
Minimally invasive spine surgery has the potential to reduce soft tissue destruction, blood loss, postoperative pain, and overall…
Expand
Highly Cited
2018
Highly Cited
2018
Interscalene Block with and without Intraoperative Local Infiltration with Liposomal Bupivacaine in Shoulder Arthroplasty: A Randomized Controlled Trial
S. Namdari
,
Thema A. Nicholson
,
J. Abboud
,
M. Lazarus
,
D. Steinberg
,
G. Williams
Journal of Bone and Joint Surgery. American…
2018
Corpus ID: 52004362
Background: Interscalene brachial plexus blockade (ISBPB) is an effective anesthetic technique for shoulder arthroplasty; however…
Expand
2017
2017
An evaluation of the analgesic effect of AnestaGel™ on mechanical allodynia in a rat model of postoperative incisional pain
J. Hutchins
,
W. Taylor
Journal of Pain Research
2017
Corpus ID: 13184279
Purpose Sustained release hydrogel with bupivacaine (AnestaGel™) is a novel formulation of extended release bupivacaine in a…
Expand
2017
2017
Abstract: Prospective Randomized Blinded Trial Investigating Pain Control and Length of Stay Measures with Transversus Abdominis Plane Block Performed with Liposomal Bound Bupivicaine (Exparel®) in…
J. Gatherwright
,
A. Ghaznavi
,
R. Knackstedt
,
R. Djohan
Plastic and Reconstructive Surgery, Global Open
2017
Corpus ID: 27453366
levels on the MPQ compared to TE/I patients two-years postoperatively, an important point to consider during preoperative…
Expand
2016
2016
Does local wound infiltration with liposomal bupivacaine (Exparel®) reduce narcotic requirements or length-of-stay after bariatric operations?
P. Ziemann-Gimmel
,
R. Marema
,
A. Goldfarb
,
M. Connelly
2016
Corpus ID: 78919915
2015
2015
Exparel®: A New Local Anesthetic with Special Safety Concerns.
M. Burbridge
,
R. Jaffe
Anesthesia and Analgesia
2015
Corpus ID: 207125631
2015
2015
Value-based Clinical Quality Improvement (CQI) for Patients Undergoing Abdominal Wall Reconstruction.
B. Stephan
,
B. Ramshaw
,
B. Forman
Surgical technology international
2015
Corpus ID: 2530947
Patients with complex ventral/incisional hernias often undergo an abdominal wall reconstruction (AWR). These operations have a…
Expand
Highly Cited
2013
Highly Cited
2013
Improving patient outcomes through advanced pain management techniques in total hip and knee arthroplasty.
J. Barrington
,
D. Dalury
,
R. Emerson
,
R. Hawkins
,
G. Joshi
,
B. Stulberg
American journal of orthopedics
2013
Corpus ID: 21094960
Pain following orthopedic surgery is common and often suboptimally managed, with many patients reporting acute moderate to severe…
Expand
Highly Cited
2011
Highly Cited
2011
Safety Evaluation of EXPAREL (DepoFoam Bupivacaine) Administered by Repeated Subcutaneous Injection in Rabbits and Dogs: Species Comparison
B. M. Richard
,
D. Rickert
,
+7 authors
K. Nelson
Journal of Drug Delivery
2011
Corpus ID: 796005
EXPAREL (bupivacaine extended-release liposome injection), DepoFoam bupivacaine, is in development for prolonged postsurgical…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE